IMMUPHARMA PLC - Major Shareholding Notification 2016

National Storage Mechanism | Additional information

RNS Number : 4207Q

Immupharma PLC

29 February 2016


TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:						Immupharma plc
2. Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights									x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation:					Lanstead Capital LP
4. Full name of shareholder(s) (if different from 3.):
5. Date of the transaction and date on which the threshold is crossed or reached:					25 February 2016
6. Date on which issuer notified:					26 February 2016
7. Threshold(s) that is/are crossed or reached:					3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%
8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction			Resulting situation after the triggering transaction
Number of Shares		Number of Voting Rights	Number of shares		Number of voting rights		% of voting rights
Direct		Direct	Indirect	Direct	Indirect
GB0033711010	0		0	17,872,341		17,872,341		15.03%


B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument		Expiration date		Exercise/ Conversion Period			Number of voting rights that may be acquired if the instrument is exercised/ converted.		% of voting rights
N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Exercise price		Expiration date		Exercise/ Conversion period	Number of voting rights instrument refers to		% of voting rights
N/A								Nominal		Delta


Total (A+B+C)
Number of voting rights						Percentage of voting rights
17,872,341						15.03%


9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
N/A

Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:
14. Contact name:	Lisa De Vargas, Lanstead Partners Limited
15. Contact telephone number:	+1 (801) 895-3700

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLDKLBLQLFEBBK

AI assistant